Bipolar Disorder News and Research RSS Feed - Bipolar Disorder News and Research

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Symptoms of bipolar disorder are severe. They are different from the normal ups and downs that everyone goes through from time to time. Bipolar disorder symptoms can result in damaged relationships, poor job or school performance, and even suicide. But bipolar disorder can be treated, and people with this illness can lead full and productive lives.
Study explores diabetes screening for patients with severe mental illness

Study explores diabetes screening for patients with severe mental illness

A study just published in the Journal of the American Medical Association Internal Medicine examines diabetes screening for patients with severe mental illness, who are two to three times more likely to have type 2 diabetes than the general population. More than seven million Americans in the United States have severe mental illness, and there are many factors contributing to their increased risk of getting diabetes, including treatment with antipsychotic medication. [More]
UCSF research on mood disorders aims to advance understanding and treatment of depression

UCSF research on mood disorders aims to advance understanding and treatment of depression

A gift of $20 million from the Ray and Dagmar Dolby Family Fund to the Department of Psychiatry at UC San Francisco will support research on mood disorders, aiming to rapidly advance the understanding and treatment of depression, bipolar disorder and related illnesses. [More]
General psychiatric support warranted in MS patients

General psychiatric support warranted in MS patients

Multiple sclerosis has a nonspecific effect on psychiatric morbidity, increasing the risk of all psychiatric disorders, shows a large population-based study. [More]
Study sheds light on mechanism of neuronal activity

Study sheds light on mechanism of neuronal activity

Neurons communicate by passing electrical messages, known as action potentials, between each other. Each neuron has a highly specialized structural region, the axon initial segment (AIS), whose primary role is in the generation and sending of these messages. [More]
Lithium chloride could offer effective treatment against osteoarthritis

Lithium chloride could offer effective treatment against osteoarthritis

Bioengineers from Queen Mary University of London have shown for the first time that lithium chloride, a common drug used to treat mental health disorders, could offer an effective treatment against osteoarthritis by disrupting the length of the cells' antennae called primary cilia. [More]
MHS receives CMMI grant to provide comprehensive healthcare to people with severe mental illness

MHS receives CMMI grant to provide comprehensive healthcare to people with severe mental illness

Montefiore Health System today announced receipt of a four-year, $9.6 million grant from the Center for Medicare and Medicaid Innovation (CMMI) to fund a unique patient-centered approach to providing comprehensive healthcare to those with severe mental illness (SMI). [More]
NHS should remove unproven apps from library, say experts

NHS should remove unproven apps from library, say experts

There is no proof that 85% of the depression apps currently recommended by the NHS for patients to manage their condition actually work, say experts in the journal Evidence Based Mental Health. [More]
Lithium can be safe, effective for children suffering from bipolar disorder

Lithium can be safe, effective for children suffering from bipolar disorder

A multicenter study of young patients with bipolar disorder provides what may be the most scientifically rigorous demonstration to date that lithium -- a drug used successfully for decades to treat adults with the condition -- can also be safe and effective for children suffering from it. [More]
New analysis finds illogical thoughts as most predictive of schizophrenia risk

New analysis finds illogical thoughts as most predictive of schizophrenia risk

Despite decades of study, schizophrenia has remained stubbornly difficult to diagnose in its earliest stage - between the appearance of symptoms and the development of the disorder. Now, a new analysis led by researchers at the UNC School of Medicine and the Renaissance Computing Institute identified illogical thoughts as most predictive of schizophrenia risk. [More]
Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults. [More]
Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

The Brain & Behavior Research Foundation will honor nine scientists with its 2015 Outstanding Achievement Prizes for their work in schizophrenia, mood disorders, child and adolescent psychiatry, and cognitive neuroscience. [More]
Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that NBI-98854, a highly selective small molecule VMAT2 inhibitor, showed a statistically significant reduction in tardive dyskinesia during the six weeks of placebo-controlled treatment in the Kinect 3 clinical trial. This Phase III trial included moderate to severe tardive dyskinesia patients with underlying schizophrenia, schizoaffective disorder, bipolar or major depressive disorder. [More]
Social dynamics, family history critical to identifying patients most likely to abuse pain medicines

Social dynamics, family history critical to identifying patients most likely to abuse pain medicines

Patients undergoing rehabilitation for physical injuries and their physicians can better understand who is most at risk of abusing opioids by reviewing their family history, lifestyle and environment for critical cues about susceptibility to addiction, according to physical medicine and rehabilitation experts. [More]
Two-drug combination relieves depression in older adults

Two-drug combination relieves depression in older adults

More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients. [More]
Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

The Brain & Behavior Research Foundation today announced the award of its NARSAD Young Investigator Grants valued at more than $13 million to 191 of the world's most promising young scientists. [More]
UCI researchers uncover new underlying factor of seizures

UCI researchers uncover new underlying factor of seizures

University of California, Irvine researchers with the School of Medicine have identified the mechanism by which valproic acid controls epileptic seizures, and by doing so, also revealed an underlying factor of seizures. [More]

Antidepressants can increase depression, mood cycling in rapid-cycling bipolar disorder patients

In patients with rapid-cycling bipolar disorder, antidepressants can increase incidents of depression and mood cycling. Rif S. El-Mallakh, M.D., director of the Mood Disorders Clinical and Research Program at the University of Louisville, along with Nassir Ghaemi, M.D., of Tufts University and other researchers, conducted the first randomized clinical trial that analyzes how modern antidepressants affect patients with rapid-cycling (RC) bipolar disorder (BD). [More]
Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

While it is known that the incidence and outward symptoms of schizophrenia are strongly influenced by ethnic factors--for instance, patients from Asian ethnicities are more likely to experience visual hallucinations, whereas patients from western cultures and Caucasian ethnicities are more likely to suffer from auditory hallucinations--it was unclear if brain deficits would differ amongst suffers from various ethnic backgrounds. [More]
Ex-prisoners with common psychiatric disorders more likely to commit violent crimes after release

Ex-prisoners with common psychiatric disorders more likely to commit violent crimes after release

Ex-prisoners with common psychiatric disorders such as bipolar disorder (manic-depressive disorder) and alcohol and drug abuse are substantially more likely to commit a violent crime after release than other prisoners, according to new research published in The Lancet Psychiatry journal. [More]
Brain scans may help predict patients' response to antipsychotic drug treatment

Brain scans may help predict patients' response to antipsychotic drug treatment

Investigators at The Feinstein Institute for Medical Research have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment. The findings are published online in the latest issue of The American Journal of Psychiatry. [More]
Advertisement
Advertisement